AVTX
Price
$4.10
Change
-$0.23 (-5.31%)
Updated
Jun 6 closing price
Capitalization
46.78M
VTGN
Price
$2.36
Change
-$0.01 (-0.42%)
Updated
Jun 6 closing price
Capitalization
68.4M
Interact to see
Advertisement

AVTX vs VTGN

Header iconAVTX vs VTGN Comparison
Open Charts AVTX vs VTGNBanner chart's image
Avalo Therapeutics
Price$4.10
Change-$0.23 (-5.31%)
Volume$89.07K
Capitalization46.78M
VistaGen Therapeutics
Price$2.36
Change-$0.01 (-0.42%)
Volume$83.85K
Capitalization68.4M
AVTX vs VTGN Comparison Chart
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. VTGN commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Buy and VTGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (AVTX: $3.59 vs. VTGN: $2.53)
Brand notoriety: AVTX and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 53% vs. VTGN: 130%
Market capitalization -- AVTX: $46.78M vs. VTGN: $68.4M
AVTX [@Biotechnology] is valued at $46.78M. VTGN’s [@Biotechnology] market capitalization is $68.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than AVTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).

  • AVTX’s TA Score: 5 bullish, 3 bearish.
  • VTGN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both AVTX and VTGN are a good buy in the short-term.

Price Growth

AVTX (@Biotechnology) experienced а -5.28% price change this week, while VTGN (@Biotechnology) price change was +4.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($68.4M) has a higher market cap than AVTX($46.8M). VTGN YTD gains are higher at: -14.237 vs. AVTX (-51.682). AVTX has higher annual earnings (EBITDA): -38.16M vs. VTGN (-52.22M). AVTX has more cash in the bank: 135M vs. VTGN (88.6M). AVTX has less debt than VTGN: AVTX (568K) vs VTGN (1.71M). VTGN has higher revenues than AVTX: VTGN (698K) vs AVTX (441K).
AVTXVTGNAVTX / VTGN
Capitalization46.8M68.4M68%
EBITDA-38.16M-52.22M73%
Gain YTD-51.682-14.237363%
P/E Ratio0.04N/A-
Revenue441K698K63%
Total Cash135M88.6M152%
Total Debt568K1.71M33%
FUNDAMENTALS RATINGS
AVTX vs VTGN: Fundamental Ratings
AVTX
VTGN
OUTLOOK RATING
1..100
428
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
9560
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (45) in the Biotechnology industry is somewhat better than the same rating for AVTX (84) in the Pharmaceuticals Other industry. This means that VTGN’s stock grew somewhat faster than AVTX’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that VTGN’s stock grew similarly to AVTX’s over the last 12 months.

VTGN's SMR Rating (97) in the Biotechnology industry is in the same range as AVTX (97) in the Pharmaceuticals Other industry. This means that VTGN’s stock grew similarly to AVTX’s over the last 12 months.

VTGN's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for AVTX (95) in the Pharmaceuticals Other industry. This means that VTGN’s stock grew somewhat faster than AVTX’s over the last 12 months.

AVTX's P/E Growth Rating (99) in the Pharmaceuticals Other industry is in the same range as VTGN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXVTGN
RSI
ODDS (%)
Bullish Trend 12 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
87%
MACD
ODDS (%)
Bullish Trend 12 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend about 1 month ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with KYMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+4.12%
KYMR - VTGN
48%
Loosely correlated
+2.35%
ABOS - VTGN
48%
Loosely correlated
N/A
ATAI - VTGN
44%
Loosely correlated
+4.52%
RCKT - VTGN
44%
Loosely correlated
+6.44%
ZYME - VTGN
44%
Loosely correlated
+0.09%
More